Search reports.
Healthcare Contract Development & Manufacturing Organization Market
Get free sample report Request for Customiztion Buy Now

Healthcare Contract Development & Manufacturing Organization Market

Segments - Healthcare Contract Development and Manufacturing Organization Market by Services (Contract Development [Preclinical {Toxicology Testing, Bioanalysis & DMPK Studios, and Other Preclinical Services}, Clinical {Phase I, Phase II, Phase III, and Phase IV}, and Laboratory Services {Analytical Services and Bioanalytical Services}] and Contract Manufacturing [API/BulknDrugs, Medical Devices {Class I, Class II, and Class III}, and Finished Dose Formulations]), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa)- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023-2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-1742 | 4.9 Rating | 85 Reviews | 184 Pages | Format : PDF Excel PPT

Report Description


Healthcare Contract Development and Manufacturing Organization Market Outlook

The global healthcare contract development and manufacturing organization market size was valued at USD 232.70 Billion in 2022 and is likely reach to USD 526.65 Billion by 2031, expanding at a CAGR of 9.5% during the forecast period, 2023-2031.

The market growth is attributed to rapid growth of the pharmaceutical industry, rise in the outsourcing by the pharmaceutical companies, and lowering the capital and operational expenses by contract development and manufacturing organization.

Healthcare Contract Development and Manufacturing Organization Market Outlook

A company that provides services such as drug development through drug manufacturing and is being served to different other pharmaceutical companies is known as contract development and manufacturing organization.

This is also widely called as a contract manufacturing organization. The outsourcing of the development and organization activities manufacturing is adopted majorly by small-sized pharmaceutical companies due to lack of internal capabilities.

The outbreak of COVID-19 pandemic had a challenging impact on the market as there are various unprecedented issues in front of the drug developers.

The pandemic has brought drastic aspects of the pharmaceutical industry starting from drug development, drug manufacturing, their supplies, their trials, and then sending it to supply chain logistics. However, all the problems mentioned are short-term and are likely to overcome as the pandemic starts subsiding.

  • Offering solutions ranging from the development of drugs to the manufacturing of drugs to all the medical & clinical device companies at one place. This is expected to drive the market growth.
  • Increasing demand for biological and molecules in developing countries and increasing number of outsourcing the manufacturing activities to development and manufacturing organizations are acting as key driving factors for the market.
  • Massive investments for research & development, expansion of capacity, and access to specialized knowledge & resources is anticipated to help in the growth of the market.
  • The intimidation of infringement of Intellectual Property (IP) rights, rise in the cost of logistics, and issues faced by healthcare organizations for sterilizations are expected to hamper the market.

Scope of Healthcare Contract Development and Manufacturing Organization Market Report

The report on the global healthcare contract development and manufacturing organization market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Healthcare Contract Development and Manufacturing Organization Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Services (Contract Development [Preclinical {Toxicology Testing, Bioanalysis & DMPK Studios, and Other Preclinical Services}, Clinical {Phase I, Phase II, Phase III, and Phase IV}, Laboratory Services {Analytical Services and Bioanalytical Services}] and Contract Manufacturing [API/BulknDrugs, Medical Devices {Class I, Class II, and Class III}, and Finished Dose Formulations])

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Catalent Inc.; Lonza Group Ltd.; Recipharm AB; Siegfried Holding AG; Thermo Fisher Scientific Inc.; Covance Inc.; Jabil; Sanmina Corp.; IQVIA Holdings Inc.; and Flex.

Healthcare Contract Development and Manufacturing Organization Market Segment Insights

Contract manufacturing is anticipated to expand at a fast CAGR

On the basis of services, the global healthcare contract development and manufacturing organization market is bifurcated into contract development and contract manufacturing. The contract development segment is further divided into preclinical, clinical, and laboratory devices.

The preclinical segment is sub-divided into toxicology testing, bioanalysis & DMPK studios, and other preclinical services. The clinical segment is further segmented into phase I, phase II, and phase III. The laboratory services are further bifurcated into analytical services and bioanalytical services.

The contract manufacturing segment is divided into API/bulk drugs, medical devices, and finished dose formulations. The medical devices segment is further divided into class I, class II, and class III.

The contract manufacturing segment held a major share of the market in 2019 with a share of more than 70.2% and is anticipated to expand at a fast CAGR over the forecast period owing to complexity in manufacturing devices coupled with rise in the use of medical devices due to increase in incidence of chronic diseases.

Healthcare Contract Development and Manufacturing Organization Market Services

Healthcare Contract Development and Manufacturing Organization Market Regional Outlook

Asia Pacific is expected to grow at a rapid pace

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a key share of the market in 2019 and is expected to continue to do so over the forecast period.

The regional market growth is attributed to increase in demand for pharmaceutical products as a result of which pharmaceutical companies start to outsource the manufacturing and development of drug to contract development and manufacturing organization.

However, the market of Asia Pacific is expected to grow at a rapid pace in the coming years owing to low cost for manufacturing as compared to Europe and North America.

Healthcare Contract Development and Manufacturing Organization Market Region

Segments

Services

  • Contract Development
    • Preclinical
      • Toxicology Testing
      • Bioanalysis & DMPK Studios
      • Preclinical Services
    • Clinical
      • Phase I
      • Phase II
      • Phase III
  • Laboratory Devices
    • Analytical Services
    • Bioanalytical Services
  • Contract Manufacturing
    • API/Bulk Drugs
    • Medical Devices
      • Class I
      • Class II
      • Class III
    • Finished Dose Formulations

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Catalent Inc.
  • Lonza Group Ltd.
  • Recipharm AB
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
  •  Covance Inc.
  • Jabil
  • Sanmina Corp.
  • IQVIA Holdings Inc.
  • Flex

Competitive Landscape

Key players competing in the global healthcare contract development and manufacturing organization market are Catalent Inc.; Lonza Group Ltd.; Recipharm AB; Siegfried Holding AG; Thermo Fisher Scientific Inc.; Covance Inc.; Jabil; Sanmina Corp.; IQVIA Holdings Inc.; and Flex.

Many of these players have adopted business strategies such as launching new products, introducing new technology, merger, partnership, and production capacity expansion to increase their market position and expand their consumer base globally.

Healthcare Contract Development and Manufacturing Organization Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Healthcare Contract Development and Manufacturing Organization Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Healthcare Contract Development and Manufacturing Organization Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Healthcare Contract Development and Manufacturing Organization Market - Supply Chain
  4.5. Global Healthcare Contract Development and Manufacturing Organization Market Forecast
     4.5.1. Healthcare Contract Development and Manufacturing Organization Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Healthcare Contract Development and Manufacturing Organization Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Healthcare Contract Development and Manufacturing Organization Market Absolute $ Opportunity
5. Global Healthcare Contract Development and Manufacturing Organization Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Healthcare Contract Development and Manufacturing Organization Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Healthcare Contract Development and Manufacturing Organization Demand Share Forecast, 2019-2026
6. North America Healthcare Contract Development and Manufacturing Organization Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Healthcare Contract Development and Manufacturing Organization Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Healthcare Contract Development and Manufacturing Organization Demand Share Forecast, 2019-2026
7. Latin America Healthcare Contract Development and Manufacturing Organization Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Healthcare Contract Development and Manufacturing Organization Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Healthcare Contract Development and Manufacturing Organization Demand Share Forecast, 2019-2026
8. Europe Healthcare Contract Development and Manufacturing Organization Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Healthcare Contract Development and Manufacturing Organization Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Healthcare Contract Development and Manufacturing Organization Demand Share Forecast, 2019-2026
9. Asia Pacific Healthcare Contract Development and Manufacturing Organization Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Healthcare Contract Development and Manufacturing Organization Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Healthcare Contract Development and Manufacturing Organization Demand Share Forecast, 2019-2026
10. Middle East & Africa Healthcare Contract Development and Manufacturing Organization Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Healthcare Contract Development and Manufacturing Organization Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Healthcare Contract Development and Manufacturing Organization Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Healthcare Contract Development and Manufacturing Organization Market: Market Share Analysis
  11.2. Healthcare Contract Development and Manufacturing Organization Distributors and Customers
  11.3. Healthcare Contract Development and Manufacturing Organization Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Catalent Inc.
     11.4.2. Lonza Group Ltd.
     11.4.3. Recipharm AB
     11.4.4. Siegfried Holding AG
     11.4.5. Thermo Fisher Scientific Inc.
     11.4.6.  Covance Inc.

Methodology

Our Clients

sinopec
Pfizer
Siemens Healthcare
Microsoft
The John Holland Group
FedEx Logistics
Dassault Aviation
Deloitte